has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale ...

Clinicians who treat patients with stroke need to be aware of several single-gene disorders that have ischemic stroke as ... as defined by transcranial Doppler ultrasonography (time-averaged ...

An ischemic stroke is a medical emergency ... we shouldn't be worried about our blood types putting us at high risk for ...

In patients with acute ischemic stroke, continuous transcranial Doppler augments t-PA-induced arterial recanalization, with a nonsignificant trend toward an increased rate of recovery from stroke ...

An ischemic stroke is a medical emergency caused by a blockage in a blood vessel that supplies blood to a region of the brain. Symptoms may include facial drooping, limb weakness on one side ...

There are two main types of stroke. An ischemic stroke is what happens when something blocks the arteries or reduces blood flow from the heart to the brain. This blockage deprives brain tissue of ...

For patients with acute ischemic stroke ... may experience another stroke. So, there is a balance between the risk and benefits. Guidelines on this issue vary widely. US guidelines recommend ...

It's also one of the top causes of disability. There are two types of stroke. Ischemic stroke is similar to a heart attack, except it occurs in the blood vessels of the brain. Clots can form in ...

A new analysis finds a significant uptick in the number of people dying at home due to ischemic ... to identify stroke. "This study shows that different populations within the US experience ...

An ischemic stroke is when a blood clot or other particles reduce blood flow to part of the brain, depriving it of oxygen. A hemorrhagic stroke occurs when a blood vessel in part of the brain ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours ... brain tissue. Another US trial (TIMELESS) failed to show a benefit ...